“The Global Biodefense Market is Estimated to Be USD 14.9 Bn in 2021 and is Expected to Reach USD 21.2 Bn by 2026, Growing at a CAGR of 7.3%
”
FEATURED COMPANIES
- Achaogen Inc
- BBI Detection Limited
- Elusys Therapeutics, Inc
- Human Genome Sciences
- Nanotherapeutics, Inc.
- Pfizer Inc
The Global Biodefense Market is estimated to be USD 14.9 Bn in 2021 and is expected to reach USD 21.2 Bn by 2026, growing at a CAGR of 7.3%.
Market Dynamics
The factors such as increasing investment by the Government, raising awareness amongst people regarding life-threatening diseases, increasing disease surveillance activities, and rising healthcare expenditure have prompted the demand of the biodefence market. In addition, the increasing use of technology advancement to increases the efficiency of the operation, such as 3D visualization and augmented reality of surgery, is further driving the market growth. However, the limited awareness amongst the developing and underdeveloped countries and limited skilled professional availability is anticipated to hinder the market growth. The market may also face possible challenges due to the high level of initial investment required.
The growing risk of terrorism, coupled with often rising pressure between nations across the world, including widespread research and development (R&D) in the field of biotechnology, is expected to generate untapped opportunities for the market.
Market Segmentation
The Global Biodefense Market is segmented further based on Products, Applications, and Geography.
By Products, the market is classified into antibiotic, biothreat detection device, and immunization vaccine, mask, and others. Amongst all, the immunization vaccine segment is estimated to hold the highest market share during the forecast period.
By Applications, the market is classified as Military and Civilian. Amongst the two, the civilian segment is estimated to hold the highest market share during the forecast period.
By Geography, North America is projected to lead the market.
Recent Developments
1. SANOFI has acquired Synthorx, its immuno-oncology pipeline, for $2. 5 Bn - 9th December 2019.
2. Pfizer and BioNTech SE received first authorization in the U.S. of vaccine to prevent Covid-19 - 11th December 2020
Company Profiles
Some of the companies covered in this report are Acambis PLC, Achaogen Inc Alnylam Pharmaceuticals Inc, Altimmune Inc, Bavarian Nordic, BBI Detection Limited, Bharat Biotech International, etc.
Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Why buy this report?
Market Dynamics
The factors such as increasing investment by the Government, raising awareness amongst people regarding life-threatening diseases, increasing disease surveillance activities, and rising healthcare expenditure have prompted the demand of the biodefence market. In addition, the increasing use of technology advancement to increases the efficiency of the operation, such as 3D visualization and augmented reality of surgery, is further driving the market growth. However, the limited awareness amongst the developing and underdeveloped countries and limited skilled professional availability is anticipated to hinder the market growth. The market may also face possible challenges due to the high level of initial investment required.
The growing risk of terrorism, coupled with often rising pressure between nations across the world, including widespread research and development (R&D) in the field of biotechnology, is expected to generate untapped opportunities for the market.
Market Segmentation
The Global Biodefense Market is segmented further based on Products, Applications, and Geography.
By Products, the market is classified into antibiotic, biothreat detection device, and immunization vaccine, mask, and others. Amongst all, the immunization vaccine segment is estimated to hold the highest market share during the forecast period.
By Applications, the market is classified as Military and Civilian. Amongst the two, the civilian segment is estimated to hold the highest market share during the forecast period.
By Geography, North America is projected to lead the market.
Recent Developments
1. SANOFI has acquired Synthorx, its immuno-oncology pipeline, for $2. 5 Bn - 9th December 2019.
2. Pfizer and BioNTech SE received first authorization in the U.S. of vaccine to prevent Covid-19 - 11th December 2020
Company Profiles
Some of the companies covered in this report are Acambis PLC, Achaogen Inc Alnylam Pharmaceuticals Inc, Altimmune Inc, Bavarian Nordic, BBI Detection Limited, Bharat Biotech International, etc.
Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Why buy this report?
- The report offers a comprehensive evaluation of the Global Biodefense Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
- The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
- The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
- The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
- The report also contains the competitive analysis using Positioning Quadrants, the analyst’s positioning tool.
- A complete analysis of the market, including parent industry
- Important market dynamics and trends
- Market segmentation
- Historical, current, and projected size of the market based on value and volume
- Market shares and strategies of key players
- Recommendations to companies for strengthening their foothold in the market
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Achaogen Inc
- BBI Detection Limited
- Elusys Therapeutics, Inc
- Human Genome Sciences
- Nanotherapeutics, Inc.
- Pfizer Inc
1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Shareholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size and Segmentation
3.3 Market Outlook
4 Market Influencers
4.1 Drivers
4.1.1 Favorable Initiatives by Government
4.1.2 Rapid Advancement in the Biotechnology
4.1.3 Rising Awareness in Disease Surveillance
4.2 Restraints
4.2.1 Large Amount of Investment
4.2.2 Limited Market Awareness
4.3 Opportunities
4.3.1 Growing Threat of Bioterrorism
4.4 Challenges
4.4.1 Requirement of Technical Skilled Person
4.5 Trends
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Biodefense Market, By Products
6.1 Introduction
6.2 Antibiotics
6.3 Biothreat Detection Device
6.3.1 Detectors/Triggering Devices
6.3.2 Assays and Reagents
6.3.3 Samplers
6.3.4 Identifiers
6.4 Immunization Vaccine
6.4.1 Anthrax
6.4.2 Smallpox
6.4.3 Botulism
6.4.4 Nuclear/Radiation
6.4.5 E-Bola
6.4.6 Zika
6.4.7 Other Vaccines
6.5 Mask
6.6 Others
7 Global Biodefense Market, By Applications
7.1 Introduction
7.2 Military
7.3 Civilian
8 Global Biodefense Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 South America
8.3.1 Brazil
8.3.2 Argentina
8.3.3 Chile
8.3.4 Colombia
8.4 Europe
8.4.1 UK
8.4.2 France
8.4.3 Germany
8.4.4 Italy
8.4.5 Spain
8.4.6 Netherlands
8.4.7 Sweden
8.4.8 Russia
8.4.9 Rest of Europe
8.5 Asia-Pacific
8.5.1 China
8.5.2 Japan
8.5.3 India
8.5.4 Indonesia
8.5.5 Malaysia
8.5.6 South Korea
8.5.7 Australia
8.5.8 Sri Lanka
8.5.9 Thailand
8.5.10 Rest of APAC
8.6 Middle-East and Africa
8.6.1 Qatar
8.6.2 Saudi Arabia
8.6.3 South Africa
8.6.4 United Arab Emirates
9 Competitive Landscape
9.1 Competitive Quadrant
9.2 Market Share Analysis
9.3 Strategic Initiatives
9.3.1 M&A and Investments
9.3.2 Partnerships and Collaborations
9.3.3 Product Developments and Improvements
10 Company Profiles
10.1 Achaogen Inc
10.2 Alnylam Pharmaceuticals, Inc
10.3 Altimmune Inc
10.4 Bavarian Nordic
10.5 BBI Detection Limited
10.6 Bharat Biotech International Limited
10.7 Bio Factura Inc
10.8 Cleveland Biolabs
10.9 Dynavax Technologies Corporation
10.10 Dynport Vaccine Company LIc
10.11 Elusys Therapeutics, Inc
10.12 Emergent BioSolution Inc
10.13 Evogen Inc
10.14 Human Genome Sciences
10.15 Icohor Medical System
10.16 Mediimmune (AstraZeneca)
10.17 Nanotherapeutics, Inc.
10.18 Ology Bioservices
10.19 PathSensor Inc
10.20 PharmaAthene Inc
10.21 Pfizer Inc
10.22 Pluristem Therapeutics
10.23 Sanofi Pasteur Ltd.
10.24 Serum Institute of India Pvt Ltd
10.25 Siga Technologies Inc
10.26 Soligenix Inc
10.27 Xoma Corporation
11 Appendix
11.1 Questionnaire
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Shareholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size and Segmentation
3.3 Market Outlook
4 Market Influencers
4.1 Drivers
4.1.1 Favorable Initiatives by Government
4.1.2 Rapid Advancement in the Biotechnology
4.1.3 Rising Awareness in Disease Surveillance
4.2 Restraints
4.2.1 Large Amount of Investment
4.2.2 Limited Market Awareness
4.3 Opportunities
4.3.1 Growing Threat of Bioterrorism
4.4 Challenges
4.4.1 Requirement of Technical Skilled Person
4.5 Trends
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Biodefense Market, By Products
6.1 Introduction
6.2 Antibiotics
6.3 Biothreat Detection Device
6.3.1 Detectors/Triggering Devices
6.3.2 Assays and Reagents
6.3.3 Samplers
6.3.4 Identifiers
6.4 Immunization Vaccine
6.4.1 Anthrax
6.4.2 Smallpox
6.4.3 Botulism
6.4.4 Nuclear/Radiation
6.4.5 E-Bola
6.4.6 Zika
6.4.7 Other Vaccines
6.5 Mask
6.6 Others
7 Global Biodefense Market, By Applications
7.1 Introduction
7.2 Military
7.3 Civilian
8 Global Biodefense Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 South America
8.3.1 Brazil
8.3.2 Argentina
8.3.3 Chile
8.3.4 Colombia
8.4 Europe
8.4.1 UK
8.4.2 France
8.4.3 Germany
8.4.4 Italy
8.4.5 Spain
8.4.6 Netherlands
8.4.7 Sweden
8.4.8 Russia
8.4.9 Rest of Europe
8.5 Asia-Pacific
8.5.1 China
8.5.2 Japan
8.5.3 India
8.5.4 Indonesia
8.5.5 Malaysia
8.5.6 South Korea
8.5.7 Australia
8.5.8 Sri Lanka
8.5.9 Thailand
8.5.10 Rest of APAC
8.6 Middle-East and Africa
8.6.1 Qatar
8.6.2 Saudi Arabia
8.6.3 South Africa
8.6.4 United Arab Emirates
9 Competitive Landscape
9.1 Competitive Quadrant
9.2 Market Share Analysis
9.3 Strategic Initiatives
9.3.1 M&A and Investments
9.3.2 Partnerships and Collaborations
9.3.3 Product Developments and Improvements
10 Company Profiles
10.1 Achaogen Inc
10.2 Alnylam Pharmaceuticals, Inc
10.3 Altimmune Inc
10.4 Bavarian Nordic
10.5 BBI Detection Limited
10.6 Bharat Biotech International Limited
10.7 Bio Factura Inc
10.8 Cleveland Biolabs
10.9 Dynavax Technologies Corporation
10.10 Dynport Vaccine Company LIc
10.11 Elusys Therapeutics, Inc
10.12 Emergent BioSolution Inc
10.13 Evogen Inc
10.14 Human Genome Sciences
10.15 Icohor Medical System
10.16 Mediimmune (AstraZeneca)
10.17 Nanotherapeutics, Inc.
10.18 Ology Bioservices
10.19 PathSensor Inc
10.20 PharmaAthene Inc
10.21 Pfizer Inc
10.22 Pluristem Therapeutics
10.23 Sanofi Pasteur Ltd.
10.24 Serum Institute of India Pvt Ltd
10.25 Siga Technologies Inc
10.26 Soligenix Inc
10.27 Xoma Corporation
11 Appendix
11.1 Questionnaire
Note: Product cover images may vary from those shown
- Achaogen Inc
- Alnylam Pharmaceuticals, Inc
- Altimmune Inc
- Bavarian Nordic
- BBI Detection Limited
- Bharat Biotech International Limited
- Bio Factura Inc
- Cleveland Biolabs
- Dynavax Technologies Corporation
- Dynport Vaccine Company LIc
- Elusys Therapeutics, Inc
- Emergent BioSolution Inc
- Evogen Inc
- Human Genome Sciences
- Icohor Medical System
- Mediimmune (AstraZeneca)
- Nanotherapeutics, Inc.
- Ology Bioservices
- PathSensor Inc
- PharmaAthene Inc
- Pfizer Inc
- Pluristem Therapeutics
- Sanofi Pasteur Ltd.
- Serum Institute of India Pvt Ltd
- Siga Technologies Inc
- Soligenix Inc
- Xoma Corporation
Note: Product cover images may vary from those shown
LOADING...
